 | Up a level |
Yeung, Andrea M; Huang, Jingtong; Pandey, Ambarish; Hashim, Ibrahim A; Kerr, David; Pop-Busui, Rodica; Rhee, Connie M; Shah, Viral N; Bally, Lia; Bayes-Genis, Antoni; Bee, Yong Mong; Bergenstal, Richard; Butler, Javed; Fleming, G Alexander; Gilbert, Gregory; Greene, Stephen J; Kosiborod, Mikhail N; Leiter, Lawrence A; Mankovsky, Boris; Martens, Thomas W; ... (2023). Biomarkers for the diagnosis of heart failure in people with diabetes: A consensus report from diabetes technology society. Progress in cardiovascular diseases, 79, pp. 65-79. Elsevier 10.1016/j.pcad.2023.05.002
McMurray, John J; Holman, Rury R; Haffner, Steven M; Bethel, M Angelyn; Holzhauer, Björn; Hua, Tsushung A; Belenkov, Yuri; Boolell, Mitradev; Buse, John B; Buckley, Brendan M; Chacra, Antonio R; Chiang, Fu-Tien; Charbonnel, Bernard; Chow, Chun-Chung; Davies, Melanie J; Deedwania, Prakash; Diem, Peter; Einhorn, Daniel; Fonseca, Vivian; Fulcher, Gregory R; ... (2010). Effect of valsartan on the incidence of diabetes and cardiovascular events. New England journal of medicine NEJM, 362(16), pp. 1477-90. Waltham, Mass.: Massachusetts Medical Society MMS 10.1056/NEJMoa1001121
Holman, Rury R; Haffner, Steven M; McMurray, John J; Bethel, M Angelyn; Holzhauer, Björn; Hua, Tsushung A; Belenkov, Yuri; Boolell, Mitradev; Buse, John B; Buckley, Brendan M; Chacra, Antonio R; Chiang, Fu-Tien; Charbonnel, Bernard; Chow, Chun-Chung; Davies, Melanie J; Deedwania, Prakash; Diem, Peter; Einhorn, Daniel; Fonseca, Vivian; Fulcher, Gregory R; ... (2010). Effect of nateglinide on the incidence of diabetes and cardiovascular events. New England journal of medicine NEJM, 362(16), pp. 1463-76. Waltham, Mass.: Massachusetts Medical Society MMS 10.1056/NEJMoa1001122
